CHM chimeric therapeutics limited

I don't mean to sound like a broken record. But, the first three...

  1. 3,140 Posts.
    lightbulb Created with Sketch. 1751
    I don't mean to sound like a broken record. But, the first three patients in the CHM CDH-17 trial were all dosed prior to 31st December 2024 (as per Quarterly released 31/01/2025).

    So we should have received: Patient 2: 90 day results. Patient 3: 60 day results. We should also be close to Patient 4: 30 day results. Patient 4 is particularly important because that is the first in the dose escalation where they receive 150 million cells rather than the 50 million received by patients 1 - 3.





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.